A
Alcista
Alcista · 25%BDMD
$3.34
Precio del escenario
$0.109
-0.007 (-6.75%)Al cierre
Loading chart…
- Máximo
- 0.115
- Apertura
- 0.095
- Precio medio ponderado por volumen
- 0.11
- Volumen
- 5.85M
- Capitalización
- —
- Mínimo
- 0.095
- Importe
- 620.79K
- EV/EBITDA, TTM
- 3.37
Baird Medical Investment Holdings Ltd is a holding company primarily engaged in the research and development, manufacture and sales of microwave ablation (MWA) medical devices. The Company’s MWA medical devices primarily include MWA needles and MWA therapeutic apparatus. The Company is also engaged in the sales of other medical devices, including catheters, ventilators, operation tables, medical gloves, syringes and other large medical machines and systems. The proprietary medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. The Company primarily conducts its businesses in the domestic market.
Análisis de IA of Baird Medical Investment Holdings Ltd (BDMD)
VenderBaird Medical Investment Holdings Ltd is not a good buy right now due to its extremely low RSI of 6.399, indicating it is oversold, and a staggering year-to-date change of -89.70%. The stock is currently trading at $0.14, down from a 52-week high of $3.70, which reflects severe financial distress and loss of investor confidence.
Métricas de valoración
El PER previsto actual de Baird Medical Investment Holdings Ltd (BDMD) es 0.99, frente a su media de 5 años de 0.98.
Escenarios de precio de Alphio AI para BDMD
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.
Cronología de eventos
Noticias
1.009-15Yahoo FinanceBaird Medical to Present at H.C. Wainwright Conference
8.508-20NewsfilterBaird Medical Secures Product Registrations in Pakistan
7.508-11NASDAQ.COMBaird Medical and Alpmed Forge Strategic Partnership for IRE Technology
- 7.508-10Newsfilter
Baird Medical Partners with Alpmed for IRE Technology Development
- 8.506-29Newsfilter
Baird Medical Successfully Launches Microwave Ablation Technology in Vietnam and Argentina
Preguntas frecuentes sobre BDMD, respondidas por Alphio AI
Baird Medical Investment Holdings Ltd is a holding company primarily engaged in the research and development, manufacture and sales of microwave ablation (MWA) medical devices. The Company’s MWA medical devices primarily include MWA needles and MWA therapeutic apparatus. The Company is also engaged in the sales of other medical devices, including catheters, ventilators, operation tables, medical gloves, syringes and other large medical machines and systems. The proprietary medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. The Company primarily conducts its businesses in the domestic market. It operates in the Healthcare sector.
Baird Medical Investment Holdings Ltd is not a good buy right now due to its extremely low RSI of 6.399, indicating it is oversold, and a staggering year-to-date change of -89.70%. The stock is currently trading at $0.14, down from a 52-week high of $3.70, which reflects severe financial distress and loss of investor confidence.
Comunidad
Más ↗
After Hours Top Gainers $SAFX $VCIG $TWG $BDMD $FUFU
Mostrar másArtículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.